Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ASTELLAS

  • FDA Approval
  • Nov. 23, 2022, 18:31 UTC
  • 31
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

ASTELLAS

  • FDA Approval
  • Nov. 23, 2022, 18:31 UTC
  • 34
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

ASTELLAS

  • FDA Approval
  • Nov. 23, 2022, 18:19 UTC
  • 31
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

ASTELLAS

  • FDA Approval
  • Nov. 23, 2022, 17:14 UTC
  • 32
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

MAIA PHARMS INC

  • FDA Approval
  • Nov. 23, 2022, 16:35 UTC
  • 33
  • 0 comments

FDA approve SINCALIDE

Comment Full text

ACTAVIS LLC

  • FDA Approval
  • Nov. 23, 2022, 13:10 UTC
  • 30
  • 0 comments

FDA approve PEMETREXED

Comment Full text

BRISTOL

  • FDA Approval
  • Nov. 23, 2022, 13:10 UTC
  • 31
  • 0 comments

FDA approve MAVACAMTEN

Comment Full text

NOVARTIS

  • FDA Approval
  • Nov. 23, 2022, 13:10 UTC
  • 47
  • 0 comments

FDA approve ALPELISIB

Comment Full text

CEPHALON

  • FDA Approval
  • Nov. 23, 2022, 13:10 UTC
  • 48
  • 0 comments

FDA approve FENTANYL CITRATE

Comment Full text

CEPHALON

  • FDA Approval
  • Nov. 23, 2022, 13:10 UTC
  • 44
  • 0 comments

FDA approve FENTANYL CITRATE

Comment Full text
  • Previous
  • 933
  • 934
  • 935
  • 936
  • 937
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398993)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243132)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin